Systemic and Central Inflammation in AD
NCT06384378
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Alzheimer Disease
Interventions
DRUG:
11C-ER176
Sponsor
The Methodist Hospital Research Institute